Clinical significance of midkine expression in pancreatic head carcinoma.
about
Pancreatic cancerReversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cellsCD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patientsPrognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinomaDIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.Retinoid signaling in pancreatic cancer, injury and regeneration.Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirusFarnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion.Midkine: a promising molecule for drug development to treat diseases of the central nervous systemMidkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.The advances of Midkine with peripheral invasion in pancreatic cancer.CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.Midkine as a prognostic biomarker in oral squamous cell carcinoma.Midkine: a novel prognostic biomarker for cancer.Midkine promotes perineural invasion in human pancreatic cancer.Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.Midkine in the pathology of cancer, neural disease, and inflammation.Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.Angiogenesis in salivary gland tumors: from clinical significance to treatment.Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells.The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopesPromotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells.Suppression of metastasis of human pancreatic cancer cells to the liver by small interfering RNA-mediated targeting of the midkine gene.Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma.Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.Midkine in inflammation.
P2860
Q27005724-715C56B8-7D6B-45CA-8ED9-74D60836F489Q28534611-0FAA0F99-34DB-40A3-BF58-741442129FB3Q30584751-0A33D0B7-6E46-43EB-B1C7-5BBFC1046266Q33698761-04E94F81-92B3-45EF-91F8-27D79F539294Q33787360-8E829DD1-2ACA-4880-8FCF-82AFF2203361Q34119073-D0F8C5F9-7BF7-4582-AEBF-8B8DBDDE0981Q34124614-4EB04D8F-F013-4C42-93B7-9ABBEECFFF4EQ34727267-CD40A03C-228A-43E6-B39C-8204448D09F7Q35701268-BF087015-F09C-4D11-BF74-3F57FFB05B00Q36160231-06CB45C0-99E9-4DFC-8A17-343405398EB3Q36250696-02004AC1-6DD7-49EF-8EE1-825B4C5D0896Q36615659-A20055BD-9756-4281-B773-28510FF6AEEFQ36858230-02141D27-47E5-4D70-9857-7C155E08A551Q37328317-B9537B16-9885-4E30-AB8E-D30047283DBFQ37649996-5ACE3C58-705E-4879-B036-7A5C491D78A5Q37885319-7442AAED-5B62-4BF6-935C-94F70E25A62EQ38020971-2AD8A362-18BE-4E89-AC00-AF88F6644023Q38181600-2AE24DE1-FC1E-4ED1-8816-D672E8136710Q38468107-1BB5C416-F4C2-4303-8015-DE67909F49EFQ39020219-3C04B210-BE11-4EFB-AE1B-76B62D73808DQ39107708-37C460A2-E982-43C5-956A-A60DB2AC2182Q39154849-5F016C2B-CD27-48B6-B2D5-AA5F4D9EA2ABQ39171951-8FB721E0-93EB-4D6C-A5F8-157F65C95093Q39937384-D46665C1-539E-47FB-BDDC-17DB9713A36BQ40922871-1C90422B-5D4A-4ACD-8C71-317EF7F313FFQ42927100-FD9B99A5-1C51-458E-A29D-B1EE2EF6B230Q43850811-7A986107-2F62-4E98-982B-62001229964AQ47167242-6B09F288-B81A-4372-8DB6-B5A5AC3B9BB5Q55110685-3F125F6B-2D5B-4A44-BB88-BCBA3B77B63AQ55648295-84FD739F-ACC1-443D-8224-50A559DFD0A0
P2860
Clinical significance of midkine expression in pancreatic head carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical significance of midkine expression in pancreatic head carcinoma.
@ast
Clinical significance of midkine expression in pancreatic head carcinoma.
@en
type
label
Clinical significance of midkine expression in pancreatic head carcinoma.
@ast
Clinical significance of midkine expression in pancreatic head carcinoma.
@en
prefLabel
Clinical significance of midkine expression in pancreatic head carcinoma.
@ast
Clinical significance of midkine expression in pancreatic head carcinoma.
@en
P2093
P2860
P356
P1476
Clinical significance of midkine expression in pancreatic head carcinoma.
@en
P2093
H Kurahara
S Natsugoe
T Yokomine
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603879
P407
P577
2007-07-10T00:00:00Z